endarterectomy after

Size: px
Start display at page:

Download "endarterectomy after"

Transcription

1 Benefit of carotid prior stroke endarterectomy after Raymond G. Makhoul, MD,* Wesley S. Moore, MD, Michael D. Colburn, MD, William J. Quifiones-Baldrich, MD, and Candace L. Vescera, RN, Los Angeles, Calif. Purpose: The benefit of carotid endarterectomy (CEA) in preventing recurrent stroke in patients who have sustained a previous stroke remains controversial. The purpose of this study was to evaluate the immediate results and long-term benefit of CEA after recovery from a prior ipsilateral stroke. Methods: Between 1980 and 1990, 85 patients underwent CEA for prior stroke with an average follow up of 54 months (range 0.3 to 130). The interval from prior stroke to CEA averaged 19.8 months (range 0.1 to 158.3). Vascular risk factors included hypertension in 70.6%, diabetes in 20.0%, history of smoking in 80.0%, and associated coronary artery disease in 51.8% of the patients. Results: There were no perioperative deaths. Four patients (4.7%) had an ipsilateral stroke within 30 days of operation. During the follow up 31 patients (36.5%) died. The leading cause of death was cardiac (54.8%) followed by cancer (16.1%). By life-table methods, the cumulative incidence of recurrent stroke at 9 years was 14% for strokes in the ipsilateral distribution, for an annual stroke risk of 1.6% per year. The cumulative incidence of stroke in other distributions was 5%, for an annual stroke risk of 2.1% per year for all strokes. When interval to operation, preoperative stroke severity, vascular risk factors, and neurologic symptoms were evaluated, no independent indicator of increased risk of recurrent postoperative stroke could be identified. Conclusion: These results demonstrate a marked improvement over the natural history and best medical therapy for these lesions as reported in the literature. We conclude that CEA is beneficial in preventing recurrent stroke in this group of patients and should be considered the appropriate management in this setting. (J VASC SURG 1993; 18: ) Vascular surgeons have traditionally considered patients with established stroke to be a higher-risk population for carotid endarterectomy. Early experience with emergency endarterectomy for acute stroke generally produced poor outcomes. 1'2 Even when operation is delayed until full neurologic recovery is achieved, the morbidity and mortality of carotid endarterectomy are believed to be higher after stroke than in those patients with lesser degrees of neuro- From the Department of Surgery, Vascular Surgery Section, UCLA School of Medicine. Supported in part by a grant from the JOASH Foundation. Presented at the Eighth Annual Meeting of the Western Vascular Society, Sonoma, Calif., lan. 9-12, Reprint requests: Wesley S. Moore, MD, , CHS, UCLA School of Medicine, Los Angeles, CA *Dr. Makhoul is currently at the Department of Surgery, Division of Vascular Surgery, Medical College of Virginia, Richmond, Va. Copyright 1993 by The Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter /93/$ /6/48587 logic injury. Although the North American Symptomatic Carotid Endarterectomy Trial unequivocally demonstrated the benefit of carotid endarterectomy in patients with transient ischemic attack, amaurosis fugax, and minor stroke, no outcome data were reported for this important subgroup of patients with established stroke. In addition, the North American Symptomatic Carotid Endarterectomy Trial was limited to patients with recent neurologic events (less than 4 months). 3 To determine the immediate and long-term benefits of carotid endarterectomy in patients with a documented previous stroke, we have reviewed a I0-year clinical experience of carotid endarterectomy for stroke. METHODS Between January 1980 and June 1990, 85 patients with a previous history of cerebral infarction in the ipsilateral carotid distribution underwent elective carotid endarterectomy at UCLA Medical Center. Only patients undergoing elective carotid endarterectomy were included in this series. Patients having 666

2 JOURNAL OF VASCULAR SURGERY Volume 18, Number 4 Makhoul et al. 667 Table I. Neurologic event severity scale ~ Neurologic Neurologic Severity grade Impairment~ symptoms signs 0 None Absent Absent 1 None Present Absent 2 None Absent Present 3 None Present Present 4 Minor, in one or more domains Present Present 5 Major, in only one domain N/A1: N/A 6 Major, in any two domains N/A N/A 7 Major, in any three domains N/A N/A 8 Major, in any four domains N/A N/A 9 Major, in all five domains N/A N/A 10 Reduced level of consciousness N/A N/A NA, Not applicable. ~Adapted from Stroke 1985;16: ?Impairment in the domains of swallowing, self-care, ambulation, communications, and comprehension. If independence is maintained despite the impairment, it is classified as minor; if independence is lost, it is classified as major. SNeurologic signs and symptoms are integrated into the higher grades of impairment. an emergency procedure, simultaneous endarterectomy combined with coronary artery bypass grafting, nonatherosclerotic carotid disease, recurrent carotid disease, or operations such as carotid-subclavian artery bypass or carotid aneurysm repair were excluded. The patients' medical records were reviewed for details regarding risk factors; location, severity, and time of stroke; angiographic and noninvasive studies; preoperative neurologic status; details of the operation; and postoperative course. Long-term follow-up data were obtained from outpatient clinic records or telephone contact with a referring physician, the patient, or the patient's family. The preoperative, postoperative, and late neurologic status of each patient was classified on a neurologic event severity scale (Table I). The event rates and survival rates were analyzed by life-table analysis. 4 The univariate and joint relationships between various potential risk factors and incidence of stroke were evaluated by logistic regression analysis. RESULTS There were 85 carotid endarterectomies performed on 85 patients who had a previous stroke in the ipsilateral carotid artery distribution. The mean age was 68 years (range 35 to 86 years). There were 50 men and 35 women. Seventy-one percent of patients had a history of hypertension, 52% had significant coronary artery disease, 20% had diabetes mellitus, and 80% gave a history of cigarette smoking. The mean neurologic event severity scale score was 2.3 (range 0.0 to 5.0). Twenty-two patients (26%) who had had a previous ipsilateral stroke were having transient ischemic attacks before operation. Table II. Preoperative strokes Patient Cause Neurologic event severity scale (preop/postop/long-term) A Embofic* 4/4/1 B Thrombosis? 4/4/4 C Embolic* 4/4/4 D Thrombosis? 3/4/1 *Patent by duplex scan, therefore presumed embolic.?thrombosis at time of reexploration. The degree of stenosis of the operated artery was greater than 70% in 56 patients (66%) and between 30% and 70% in 20 cases (23%). Nine patients (11%) had less than 30% stenosis but had significant ulcerated plaques on angiography. The mean time interval from stroke to operation was 19.8 months (range 0.1 to 158 months). Twenty-eight (33%) patients underwent carotid endarterectomy within 6 weeks of the stroke; the remaining 57 (67%) had operation after 6 weeks. An indwelling shunt was used in 62 (73%) of cases. The carotid artery was closed primarily in 77 (91%) of patients, with patch closure used in the remaining 9%. There were no perioperative deaths. Four patients had a stroke in the ipsilateral carotid artery distribution within 30 days of operation, for a perioperative stroke rate of 4.7%. The details of these events are shown in Table II. One (3.6%) of 28 patients who underwent operation within 6 weeks of the initial stroke had a perioperative stroke. Three (5.2%) of 57 patients who received operation at a time more than 6 weeks after the initial stroke

3 JOURNAL OF VASCULAR SURGERY 668 _Makhoul et al. October 1993 A g ~oo a m L. 14 > '.~ 60 ~a 60 o~ E,-,1 o 20 2O 0 I r i I I I I I I i I Fig. 1. Cumulative survival ectomy. Months after carotid endarter- 0 i 0 I I I I I I I I i I I I I I I I I Months Fig. 3. Cumulative stroke-free rate after carotid endarterectomy for strokes in all distributions. == I.I O L ] 0 I I I I I I I I I ~ 1 ~ I I I I I i Months Fig. 2. Cumulative ipsilateral stroke-free rate after carotid endarterectomy. had a perioperative stroke. One patient had amaurosis fugax on the first postoperative day and was returned to the operating room and found to have a thrombosed external carotid artery. This was opened, and the patient had no postoperative sequelae. Three patients (3.5%) had cranial nerve palsies after carotid endarterectomy. One patient had a seventh nerve paresis, which was permanent; one a temporary twelfth nerve paresis, which resolved after 6 weeks; and the third had injury to the glossopharyngeal nerve and had dysphagia, which requires a gastrostomy tube 2 years after operation. There was an 8.5% incidence of associated postoperative morbidity including four neck hematomas that required operative drainage, one intraoperative cardiac arrest, and two cases of pulmonary complications that resolved. At the time of this review, follow-up information was complete in 73 patients (86%). The mean follow-up interval in this group of patients was 53.9 months (range 0.3 to months). During the follow-up interval 31 (36.5%) patients are known to have died. Cardiac disease was the most common cause of death (55%), followed by cancer (16%), stroke (6%), and pulmonary insufficiency (6%); 16% of patients died of a variety of other causes. The overall survival rate calculated by the life-table method was 77% at 3 years, 71% at 5 years, and 54% at 10 years (Fig. 1). Thus the average mortality rate was 4.6% per year. Six patients had a late stroke in the vascular distribution of the operated carotid artery. These strokes occurred at 2, 3, 7, 24, 36, and 42 months after operation. Two of these patients died as a result of the stroke. The occurrence of late strokes in the ipsilateral distribution is analyzed by life tables in Fig. 2. At 9 years the cumulative stroke-free rate was 86%. Therefore the annualized ipsilateral stroke risk was 1.6% per year. There were an additional three strokes that occurred in other distributions during the period of follow up, which yields an annual stroke risk of 2.1% per year for all strokes (Fig. 3). When the variables interval to operation, preoperative stroke

4 JOURNAL OF VASCULAR SURGERY Volume 18, Number 4 3/iakhoul et al. 669 severity, vascular risk factors, and neurologic symptoms were evaluated, no independent predictor of increased risk of recurrent postoperative stroke could be identified (2 > 0.05). DISCUSSION It is estimated that one half of strokes may be related to disease at the carotid bifurcation and thus be potentially amenable to surgical intervention by carotid endarterectomy, s Patients with carotid disease who have had a minor stroke and are left with minimal or no deficit are at risk for further cerebral infarction. Studies of the natural history of such patients show that their risk of recurrent stroke is 5% to 20% per year, with an average recurrence of 50% at 5 years. 6"9 It should be noted that these are old studies that predate the diagnostic techniques currently available and relate to the incidence of strokes in all distributions. As such, they may not exactly mirror the group of patients described in this and other surgical series. Medical management has included the administration of antiplatelet agents or oral anticoagulants (warfarin). But a prospective, randomized trial of aspirin versus placebo in patients with stroke and carotid disease failed to demonstrate any reduction in subsequent strokes with aspirin. At 2 years the recurrence rates for the aspirin and placebo groups were 12% and 13%, respectively) More recently, ticlopidine, a new antiplatelet agent, has been evaluated for the prevention of recurrent stroke in patients with a completed stroke. These results showed that ticlopidine was somewhat more effective than aspirin for reducing the risk of recurrent stroke, but there was still a 5% incidence of stroke in all distributions at 1 year. H Operation for the treatment of carotid disease after stroke has been controversial, both with regard to timing of operation and its benefit in preventing recurrent stroke. The reported outcome of emergency endarterectomy for acute stroke was generally poor with significant morbidity and mortality. 1'2 Often, this was because of the conversion of a bland to a hemorrhagic infarct. On the basis of these results, an arbitrary delay of 6 weeks before the performance of carotid endarterectomy was recommended. Subsequent studies by Whittemore and Mannick 12 and Piotrowski et al)3 have demonstrated that this delay is not required to prevent perioperative neurologic complications and that operation can be safely performed when neurologic recovery has reached a plateau. In these and other series, the perioperative stroke rate ranges from 0% to 8%, with a perioper- ative death rate of 0% to 6%) 1"16 The results of the present series compare favorably with these results, with a combined perioperative mortality and stroke rate of 4.7%. In addition, no difference was found in the incidence of perioperative stroke between patients operated on early (less than 6 weeks after stroke) versus late (more than 6 weeks). However, these results must be viewed in the context of the selection process to determine the timing of intervention. It has been the practice at UCLA to follow the clinical course of the stroke patient, and once the patient has achieved maximum recovery from the initial stroke, an assessment is made as to the amount of cerebral function that is left to lose. If the patient has considerable function left at risk, work-up leading to possible carotid endarterectomy is undertaken and operation is done without delay when appropriate carotid pathologic conditions are uncovered. Whether endarterectomy is beneficial in preventing recurrent stroke has been retrospectively studied by others. Bardin et al) 6 reviewed their results from 127 carotid endarterectomies in 107 patients with completed stroke. The combined perioperative morbidity and mortality rate was 7%, with a cumulative 5-year late stroke incidence of 20%. They concluded that operation for the prevention of recurrent stroke carries a high risk and that it may not be superior to a nonoperative approach. Subsequent reviews have demonstrated a beneficial effect of operation, with recurrent stroke rates ranging from 0% to 3% per year) 7z With the use of life-table methods, our series demonstrated a cumulative incidence of recurrent stroke in the ipsilateral distribution at 9 years of 14%, which yields an annual stroke risk of 1.6% per year. For all strokes, the cumulative incidence was 19%, for an annual stroke risk of 2.1% per year. These results represent a marked improvement over the natural history of the disease as reported in the literature. In addition, these are superior to reported results with use of the best medical management. Thus our results, with a mean follow up of 4.5 years, strongly favor the efficacy of endarterectomy in the prevention of recurrent stroke. One concern about carotid endarterectomy has been that patients treated in this fashion might have a shortened life expectancy, thus negating the benefits of prophylaxis from recurrent stroke. In this report, there were no perioperative deaths or myocardial infarctions, and although the most common cause of late death was cardiac, the patient survival rate was

5 670 A/Iakhoul et al. JOURNAL OF VASCULAR SURGERY October % at 5 years. Therefore it seems that these patients do survive, further justifying an aggressive approach to prevent recurrent stroke. On the basis of these results we conclude that carotid endarterectomy after prior stroke can be performed safely and effectively. In addition, operation affords significant protection from recurrent ipsilateral stroke in the long term and should be considered the treatment of choice. REFERENCES 1. Wylie EJ, Hein MF, Adams JE. Intracranial hemorrhage following surgical revascularization for treatment of acute strokes. J Neurosurg 1964;21: Rob CG. Operation for acute completed stroke due to thrombosis of the internal carotid artery. Surgery 1969;65: North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high grade stenosis. N Engl J Med 1991;325: Baker JD, Rutherford RB, Bernstein EF, et al. Suggested standards for reports dealing with cerebrovascular disease. J VASC SURG 1988;8: Mohr JP, Caplan LR, Melski JW, et al. The Harvard Cooperative Stroke Registry: a prospective registry. Neurology 1978;28: Robinson RW, Dimirel M, LeBeau RJ. Natural history of cerebral thrombosis: 9-19 year follow-up. J Chron Dis 1968;21: Enger E, Boyesen S. Long-term anticoagulant therapy in patients with cerebral infarction: a controlled clinical study. Acta Med Scand 1965 ;178: Baker RN, Schwart WS, Ranseyer JC. Prognosis among survivors of ischemic stroke. Neurology 1968; 18: Sacco RL, Wolf BA, Kannel WB, McNamara BM. Survival and recurrence following stroke: the Framingham study. Stroke 1982;13: Britton M, Helmers C, Samuelson K, et al. High-dose acetylsalicylic acid after cerebral infarction-a Swedish cooperative study. Stroke 1987;18: Harbison JW. Ticlopidine versus aspirin for the prevention of recurrent stroke. Stroke 1992;23: Whittemore AD, Mannick JA. Surgical treatment of carotid disease in patients with neurologic deficits. J VASC SFRG 1987;5: Piotrowski JJ, Bernhard VM, Rubin JR, et al. Timing of carotid endarterectomy after acute stroke. J VASC SURG 1990;11: Giordano JM, Trout HH III, Kozloff L, DePalma RG. Timing of carotid endarterectomy after stroke. ~ VAsc SURG 1985;2: Takolander RJ, Bergentz SE, Ericsson BF. Carotid artery surgery in patients with minor stroke. Br J Surg 1983;70: Bardin JA, Bernstein EF, Humber PB, et al. Is carotid endarterectomy beneficial in prevention of recurrent stroke? Arch Surg 1982;117: Rubin JR, Goldstone J, Mclntyre KE, Malone JM, Bernhard VM. The value of carotid endarterectomy in reducing the morbidity and mortality of recurrent stroke. J VASC SURG 1986;4: McCullough JL, Mentzer RM, Harman PK, Kaiser DL, Kron IL, Crosby IK. Carotid endarterectomy after a completed stroke: reduction in long-term neurologic deterioration. J VASC SURG 1985;2: Rosenthal D, Borreno E, Clark MD, Lamis PA, Daniel WW. Carotid endarterectomy after reversible ischemic neurologic deficit or stroke: Is it of value? J VASC SURG 1988;8: Hertzer NA, Arison R. Cumulative stroke and survival ten years after carotid endarterectomy. J VAsc SURG 1985;2: Submitted Feb. 23, 1993; accepted May 7, DISCUSSION Dr. Eugene F. Bernstein (La Jolla, Calif.). We should be grateful to Dr. Makhoul and his associates for providing us with additional documentation regarding the relative safety of carotid surgery in the post-stroke patient, particularly when the selection process has been careful, and the surgical group is skillful. Certainly, the data from NASCET, the VA and ECST have provided sound and convincing data regarding the superiority of surgical therapy for patients with transient symptoms associated with high-grade carotid artery stenoses. However, no such data exist regarding the benefits of surgery after a stroke. Did all the patients have severe degrees of carotid artery stenosis? Many surgeons believe that routine shunting is appropriate for carotid artery surgery in patients who had had a stroke. Because shunts were not used in all of these operations, was the operative stroke rate different in those patients who were not shunted? What was the relationship of operative and late morbidity and mortality rates to the severity of preoperative neurologic deficit? Are symptoms and signs the best criteria for the selection of such patients for carotid artery surgery? What about the infarct size data from CT/MRI scanning, and the distribution and extent of the cerebrovascular arterial disease as factors in predicting the likelihood of operative or late postoperative stroke or death? What is the importance of contralateral disease in this equation? The NASCET data show no effect of timing of carotid endarterectomy on morbidity or mortality rates after stroke. Have you reviewed this question, and do you have a recommendation regarding the appropriate interval to wait after a patient with a stroke has become neurologically stable? This presentation highlights the need to perform a more careful analysis of the important factors that may

6 IOURNAL OF VASCULAR SURGERY Volume 18, Number 4 Makhoul et al. 671 contribute to the decision for or against carotid artery surgery. Dr. Raymond Makhoul. Most of these patients had a greater than 70% stenosis. Some patients underwent operation for lesser degrees of stenosis or for ulceration. In terms of shunting, shunts were not used in all of these patients. There was no difference between the shunted and unshunted groups with respect to perioperative stroke rate. It is the practice of the senior author to shunt all patients with previous stroke. However, some of the other surgeons used selective shunting. With regard to the relationship of operative and late morbidity rates to the severity of the preoperative neurologic deficit, we studied the Neurologic Event Severity Scale score as an indicator of recurrent stroke and found it not to be a significant indicator of that. We did not examine it in relationship to survival rates. With regard to the timing of surgery after stroke, there was no difference when we stratified patients undergoing surgery within 6 weeks and greater than 6 weeks after the initial stroke. It is our practice to perform surgery at the plateau of the neurologic recovery after the initial stroke. Dr. Victor Bernhard (Tucson, Ariz.). We have reported on 129 patients who underwent operation after stroke, most of whom underwent operation within 6 weeks of the ischemic episode after neurologic recovery had reached a plateau. Similar to our experience, the operative deficit rate in this report is not significantly different from that in patients who have not had a previous stroke. This leads me to conclude that perioperative stroke-related problems are primarily related to operative technique. They are most likely thromboembolic phenomena and probably not a result of some unexplained pathophysiologic intracerebral process related to the previous stroke. In review of our concurrent experiences, what do you think is the most likely cause of deficits in patients undergoing carotid endarterectomy after recovery from a stroke! Dr. Makhoul. In this series of patients, there were four perioperafive events. Two of these were due to thrombosis of the vessel and two were likely thromboembolic. Therefore I agree with your comments. Dr. Hugh Beebe (Toledo, Ohio). Patients that I've seen have had a stroke fairly recently, and I'm not sure how much to apply these data to that problem. A mean of 19 months since the time of stroke when you perform a carotid endarterectomy indicates to me that there is a selection process. The patients who eventually found their way to you a year and a half after their stroke were a selected set of pretty good patients. Can we apply your data to the patient who had a stroke last week? Dr. Makhoul. I certainly agree that there's a spectrum in terms of the timing of surgery. However, a third of our patients did have surgery within six weeks of their stroke. Dr. Ka i ]ohansen (Seattle, Wash.). Although the leading cause of death in patients with cerebrovascular disease is coronary artery disease, it's critical for us to recall that, for at least 5 years after a stroke, the leading cause of death in a stroke victim is another stroke. In a series of 58 patients who underwent operation with prior ipsilateral stroke, contralateral occlusion, and other high-risk criteria with local or regional anesthesia, the use of a shunt was reduced to 4.5 %, and the perioperative stroke plus death rate to 1.9%. Would you comment on the use of "awake" anesthesia, which eliminates the requirement for any other means of monitoring the adequacy of cerebral peffusion? Dr. Makhoul. I can't comment with regard to this series because all of these patients underwent operation receiving general anesthetic.

Carotid Endarterectomy after Ischemic Stroke Is there a Justification for Delayed Surgery?

Carotid Endarterectomy after Ischemic Stroke Is there a Justification for Delayed Surgery? Eur J Vasc Endovasc Surg 30, 36 40 (2005) doi:10.1016/j.ejvs.2005.02.045, available online at http://www.sciencedirect.com on Carotid Endarterectomy after Ischemic Stroke Is there a Justification for Delayed

More information

Preoperative risk factors for carotid endarterectomy: Defining the patient at high risk

Preoperative risk factors for carotid endarterectomy: Defining the patient at high risk Preoperative risk factors for carotid endarterectomy: Defining the patient at high risk Amy B. Reed, MD, a Peter Gaccione, MA, b Michael Belkin, MD, b Magruder C. Donaldson, MD, b John A. Mannick, MD,

More information

Treatment Considerations for Carotid Artery Stenosis. Danielle Zielinski, RN, MSN, ACNP Rush University Neurosurgery

Treatment Considerations for Carotid Artery Stenosis. Danielle Zielinski, RN, MSN, ACNP Rush University Neurosurgery Treatment Considerations for Carotid Artery Stenosis Danielle Zielinski, RN, MSN, ACNP Rush University Neurosurgery 4.29.2016 There is no actual or potential conflict of interest in regards to this presentation

More information

03/30/2016 DISCLOSURES TO OPERATE OR NOT THAT IS THE QUESTION CAROTID INTERVENTION IS INDICATED FOR ASYMPTOMATIC CAROTID OCCLUSIVE DISEASE

03/30/2016 DISCLOSURES TO OPERATE OR NOT THAT IS THE QUESTION CAROTID INTERVENTION IS INDICATED FOR ASYMPTOMATIC CAROTID OCCLUSIVE DISEASE CAROTID INTERVENTION IS INDICATED FOR ASYMPTOMATIC CAROTID OCCLUSIVE DISEASE Elizabeth L. Detschelt, M.D. Allegheny Health Network Vascular and Endovascular Symposium April 2, 2016 DISCLOSURES I have no

More information

Post-op Carotid Complications A Nursing Perspective of What to Watch Out for

Post-op Carotid Complications A Nursing Perspective of What to Watch Out for Post-op Carotid Complications A Nursing Perspective of What to Watch Out for By Kariss Peterson, ARNP Swedish Medical Center Inpatient Neurology Team 1 Post-op Carotid Management Objectives Review the

More information

APPENDIX A NORTH AMERICAN SYMPTOMATIC CAROTID ENDARTERECTOMY TRIAL

APPENDIX A NORTH AMERICAN SYMPTOMATIC CAROTID ENDARTERECTOMY TRIAL APPENDIX A Primary Findings From Selected Recent National Institute of Neurological Disorders and Stroke-Sponsored Clinical Trials That Have shaped Modern Stroke Prevention Philip B. Gorelick 178 NORTH

More information

Updated Society for Vascular Surgery guidelines for management of extracranial carotid disease: Executive summary

Updated Society for Vascular Surgery guidelines for management of extracranial carotid disease: Executive summary SOCIETY FOR VASCULAR SURGERY DOCUMENT Updated Society for Vascular Surgery guidelines for management of extracranial carotid disease: Executive summary John J. Ricotta, MD, a Ali AbuRahma, MD, FACS, b

More information

Original Contributions. Prospective Comparison of a Cohort With Asymptomatic Carotid Bruit and a Population-Based Cohort Without Carotid Bruit

Original Contributions. Prospective Comparison of a Cohort With Asymptomatic Carotid Bruit and a Population-Based Cohort Without Carotid Bruit 98 Original Contributions Prospective Comparison of a Cohort With Carotid Bruit and a Population-Based Cohort Without Carotid Bruit David O. Wiebers, MD, Jack P. Whisnant, MD, Burton A. Sandok, MD, and

More information

The value of carotid endarterectomy in reducing the morbidity and mortality of recurrent stroke

The value of carotid endarterectomy in reducing the morbidity and mortality of recurrent stroke The value of carotid endarterectomy in reducing the morbidity and mortality of recurrent stroke Jeffrey R. Rubin, M.D., Jerry Goldstone, M.D.,* Kenneth E. McIntyre, Jr., M.D., James M. Malone, M.D., and

More information

Carotid Endarterectomy for Symptomatic Complete Occlusion of the Internal Carotid Artery

Carotid Endarterectomy for Symptomatic Complete Occlusion of the Internal Carotid Artery 2011 65 4 239 245 Carotid Endarterectomy for Symptomatic Complete Occlusion of the Internal Carotid Artery a* a b a a a b 240 65 4 2011 241 9 1 60 10 2 62 17 3 67 2 4 64 7 5 69 5 6 71 1 7 55 13 8 73 1

More information

Carotid endarterectomy to correct asymptomatic carotid stenosis: Ten years

Carotid endarterectomy to correct asymptomatic carotid stenosis: Ten years Carotid endarterectomy to correct asymptomatic carotid stenosis: Ten years later David Rosenthal, M.D., Randal Rudderman, M.D., Edgar Borrero, M.D., David H. Hafner, M.D., Garland D. Perdue, M.D., Pano

More information

The superiority of synthetic arterial grafts over autologous veins in carotid-subclavian bypass

The superiority of synthetic arterial grafts over autologous veins in carotid-subclavian bypass The superiority of synthetic arterial grafts over autologous veins in carotid-subclavian bypass Stanley Ziomek, M.D., William J. Quifiones-Baldrich, M.D., Ronald W. Busuttil, M.D., Ph.D., J. Dennis Baker,

More information

Guidelines for Ultrasound Surveillance

Guidelines for Ultrasound Surveillance Guidelines for Ultrasound Surveillance Carotid & Lower Extremity by Ian Hamilton, Jr, MD, MBA, RPVI, FACS Corporate Medical Director BlueCross BlueShield of Tennessee guidelines for ultrasound surveillance

More information

Carotid Artery Disease and What s Pertinent JOSEPH A PAULISIN DO

Carotid Artery Disease and What s Pertinent JOSEPH A PAULISIN DO Carotid Artery Disease and What s Pertinent JOSEPH A PAULISIN DO Goal of treatment of carotid disease Identify those at risk of developing symptoms Prevent patients at risk from developing symptoms Prevent

More information

Accumulating evidence from randomized, controlled trials shows that carotid. Efficacy versus Effectiveness of Carotid Endarterectomy

Accumulating evidence from randomized, controlled trials shows that carotid. Efficacy versus Effectiveness of Carotid Endarterectomy BACK OF THE ENVELOPE DAVID A. GOULD, MD Research Fellow VA Outcomes Group Department of Veterans Affairs Medical Center White River Junction, Vt Resident Department of Dartmouth Medical School Hanover,

More information

Debata II: Carotidal stenting v.s. carotidal endatherectomy- surgical side

Debata II: Carotidal stenting v.s. carotidal endatherectomy- surgical side Debata II: Carotidal stenting v.s. carotidal endatherectomy- surgical side Academician Mitrev Z, Special hospital for surgery Filip Vtori Skopje - Macedonija Oktomvri, 2008 History Hippocrates, 400 B.C.

More information

Carotid Stenosis 1/24/2019. Review of Primary Studies. NASCET- Moderate stenosis. ACAS (Asymptomatic Carotid Atherosclerosis Study) NASCET

Carotid Stenosis 1/24/2019. Review of Primary Studies. NASCET- Moderate stenosis. ACAS (Asymptomatic Carotid Atherosclerosis Study) NASCET Review of Primary Studies Carotid Stenosis NINDS National Institute of Neurological Disorders and Stroke 2 large studies to determine who would benefit from surgery NASCET North American Symptomatic Carotid

More information

UPMC HAMOT CAROTID ARTERY DISEASE WHERE DO WE GO FROM HERE?

UPMC HAMOT CAROTID ARTERY DISEASE WHERE DO WE GO FROM HERE? UPMC HAMOT CAROTID ARTERY DISEASE WHERE DO WE GO FROM HERE? Richard W. Petrella M.D. FACP,FACC,FASCI DEPARTMENT CHAIRMAN CVM&S UPMC HAMOT MEDICAL CENTER 1 LEARNING OBJECTIVES REVIEW THE RISK FACTORS FOR

More information

MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS. 73 year old NS right-handed male applicant for $1 Million life insurance

MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS. 73 year old NS right-handed male applicant for $1 Million life insurance MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS October 17, 2012 AAIM Triennial Conference, San Diego Robert Lund, MD What Is The Risk? 73 year old NS right-handed male applicant for $1

More information

Rethinking The Six Weeks Waiting Approach To Carotid Intervention After Ischemic Stroke

Rethinking The Six Weeks Waiting Approach To Carotid Intervention After Ischemic Stroke ISPUB.COM The Internet Journal of Surgery Volume 11 Number 1 Rethinking The Six Weeks Waiting Approach To Carotid Intervention After Ischemic Stroke F Aziz Citation F Aziz. Rethinking The Six Weeks Waiting

More information

CAROTID DEBATE High-Grade Asymptomatic Disease Should Be Repaired Selectively; Medical Management is NOT Enough

CAROTID DEBATE High-Grade Asymptomatic Disease Should Be Repaired Selectively; Medical Management is NOT Enough Todd W GenslerMD April 28, 2018 CAROTID DEBATE High-Grade Asymptomatic Disease Should Be Repaired Selectively; Medical Management is NOT Enough DISCLOSURES I have no financial disclosures Presenter name

More information

GUIDELINE FOR RECOVERY ROOM MANAGEMENT OF PATIENTS AFTER CAROTID ENDARTERECTOMY

GUIDELINE FOR RECOVERY ROOM MANAGEMENT OF PATIENTS AFTER CAROTID ENDARTERECTOMY GUIDELINE FOR RECOVERY ROOM MANAGEMENT OF PATIENTS AFTER CAROTID ENDARTERECTOMY Full Title of Guideline: Author (include email and role): Guideline for Recovery Room Management of Patients after Carotid

More information

Antithrombotic therapy in patients with transient ischemic attack / stroke (acute phase <48h)

Antithrombotic therapy in patients with transient ischemic attack / stroke (acute phase <48h) Antithrombotic therapy in patients with transient ischemic attack / stroke (acute phase

More information

Michael Horowitz, MD Pittsburgh, PA

Michael Horowitz, MD Pittsburgh, PA Michael Horowitz, MD Pittsburgh, PA Introduction Cervical Artery Dissection occurs by a rupture within the arterial wall leading to an intra-mural Hematoma. A possible consequence is an acute occlusion

More information

Cerebrovascular Disease. RTC Conference Resident Presenter: Dr. Christina Bailey Faculty: Dr. Jeff Dattilo October 2, 2009

Cerebrovascular Disease. RTC Conference Resident Presenter: Dr. Christina Bailey Faculty: Dr. Jeff Dattilo October 2, 2009 Cerebrovascular Disease RTC Conference Resident Presenter: Dr. Christina Bailey Faculty: Dr. Jeff Dattilo October 2, 2009 Cerebrovascular Disease Stroke is the 3 rd leading cause of death and the leading

More information

MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS. 73 year old NS right-handed male applicant for $1 Million Life Insurance

MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS. 73 year old NS right-handed male applicant for $1 Million Life Insurance MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS October 17, 2012 AAIM Triennial Conference, San Diego Robert Lund, MD What Is The Risk? 73 year old NS right-handed male applicant for $1

More information

THE incidence of stroke after noncardiac surgery

THE incidence of stroke after noncardiac surgery Lack of Association between Carotid Artery Stenosis and Stroke or Myocardial Injury after Noncardiac Surgery in High-risk Patients ABSTRACT Background: Whether carotid artery stenosis predicts stroke after

More information

Carotid endarterectomy after reversible ischemic neurologic deficit or stroke: Is it of value?

Carotid endarterectomy after reversible ischemic neurologic deficit or stroke: Is it of value? Carotid endarterectomy after reversible ischemic neurologic deficit or stroke: Is it of value? David Rosenthal, MD, Edgar Borrero, MD, Michael D. Clark, MD, Pano A. Lamis, MD, and Wayne W. Daniel, Phl),

More information

TCAR: TransCarotid Artery Revascularization Angela A. Kokkosis, MD, RPVI, FACS

TCAR: TransCarotid Artery Revascularization Angela A. Kokkosis, MD, RPVI, FACS TCAR: TransCarotid Artery Revascularization Angela A. Kokkosis, MD, RPVI, FACS Assistant Professor of Surgery Director of Carotid Interventions Division of Vascular & Endovascular Surgery Stony Brook University

More information

Risk Factors for Ischemic Stroke: Electrocardiographic Findings

Risk Factors for Ischemic Stroke: Electrocardiographic Findings Original Articles 232 Risk Factors for Ischemic Stroke: Electrocardiographic Findings Elley H.H. Chiu 1,2, Teng-Yeow Tan 1,3, Ku-Chou Chang 1,3, and Chia-Wei Liou 1,3 Abstract- Background: Standard 12-lead

More information

Nicolas Bianchi M.D. May 15th, 2012

Nicolas Bianchi M.D. May 15th, 2012 Nicolas Bianchi M.D. May 15th, 2012 New concepts in TIA Differential Diagnosis Stroke Syndromes To learn the new definitions and concepts on TIA as a condition of high risk for stroke. To recognize the

More information

Fast-track CEA: a 3-year experience

Fast-track CEA: a 3-year experience Fast-track CEA: a 3-year experience Giorgio L. Poletto, MD Milano, Italy 6th ACST-2 Collaborators Meeting, Palau de Congresos, Valencia. 24th and 25th September 2018. Stroke prevention Primary prevention:

More information

TIA SINGOLO E IN CRESCENDO: due diversi scenari della rivascolarizzazione urgente carotidea

TIA SINGOLO E IN CRESCENDO: due diversi scenari della rivascolarizzazione urgente carotidea TIA SINGOLO E IN CRESCENDO: due diversi scenari della rivascolarizzazione urgente carotidea R. Pini, G.L. Faggioli, M. Gargiulo, E. Pisano, A. Pilato, E. Gallitto, C. Mascoli, L.M. Cacioppa, A. Vacirca,

More information

Carotid Artery Surgery for the Prevention and Treatment of Ischemic Stroke Update 2015

Carotid Artery Surgery for the Prevention and Treatment of Ischemic Stroke Update 2015 Carotid Artery Surgery for the Prevention and Treatment of Ischemic Stroke Update 2015 John L. Crawford, MD, FACS Neuroscience Summit 2015 UNT Health Sciences Center September 12, 2015 www.cdc.gov/datastatistics2013

More information

Disclosures. State of the Art Management of Carotid Stenosis. NIH funding for clinical trials Consultant for Scientia Vascular and Medtronic

Disclosures. State of the Art Management of Carotid Stenosis. NIH funding for clinical trials Consultant for Scientia Vascular and Medtronic State of the Art Management of Carotid Stenosis Mark R. Harrigan, MD UAB Stroke Center Professor of Neurosurgery, Neurology, and Radiology University of Alabama, Birmingham Disclosures NIH funding for

More information

New Trials in Progress: ACT 1. Jon Matsumura, MD Cannes, France June 28, 2008

New Trials in Progress: ACT 1. Jon Matsumura, MD Cannes, France June 28, 2008 New Trials in Progress: ACT 1 Jon Matsumura, MD Cannes, France June 28, 2008 Faculty Disclosure I disclose the following financial relationships: Consultant, CAS training director, and/or research grants

More information

Carotid Revascularization

Carotid Revascularization Options for Carotid Disease Carotid Revascularization Wayne Causey, MD 2 nd Year Vascular Surgery Fellow Best medical therapy, Carotid Endarterectomy, and Carotid Stenting Who benefits from best medical

More information

Vivek R. Deshmukh, MD Director, Cerebrovascular and Endovascular Neurosurgery Chairman, Department of Neurosurgery Providence Brain and Spine

Vivek R. Deshmukh, MD Director, Cerebrovascular and Endovascular Neurosurgery Chairman, Department of Neurosurgery Providence Brain and Spine Vivek R. Deshmukh, MD Director, Cerebrovascular and Endovascular Neurosurgery Chairman, Department of Neurosurgery Providence Brain and Spine Institute The Oregon Clinic Disclosure I declare that neither

More information

Co chce/čeká neurochirug od anesteziologa během karotické endarterektomie?

Co chce/čeká neurochirug od anesteziologa během karotické endarterektomie? XXV. kongres České společnosti anesteziologie, resuscitace a intenzivní medicíny, Praha 3.-5.10. 2018 Co chce/čeká neurochirug od anesteziologa během karotické endarterektomie? Hejčl A., Orlický M., Sameš

More information

CEA and cerebral protection Volodymyr labinskyy, MD

CEA and cerebral protection Volodymyr labinskyy, MD CEA and cerebral protection Volodymyr labinskyy, MD VA Hospital 7/26/2012 63 year old male presents for the vascular evaluation s/p TIA in January 2012 PMH: HTN, long term active smoker, Hep C PSH: None

More information

CEREBRO VASCULAR ACCIDENTS

CEREBRO VASCULAR ACCIDENTS CEREBRO VASCULAR S MICHAEL OPONG-KUSI, DO MBA MORTON CLINIC, TULSA, OK, USA 8/9/2012 1 Cerebrovascular Accident Third Leading cause of deaths (USA) 750,000 strokes in USA per year. 150,000 deaths in USA

More information

Carotid Artery Revascularization: Current Strategies. Shonda Banegas, D.O. Vascular Surgery Carondelet Heart and Vascular Institute September 6, 2014

Carotid Artery Revascularization: Current Strategies. Shonda Banegas, D.O. Vascular Surgery Carondelet Heart and Vascular Institute September 6, 2014 Carotid Artery Revascularization: Current Strategies Shonda Banegas, D.O. Vascular Surgery Carondelet Heart and Vascular Institute September 6, 2014 Disclosures None 1 Stroke in 2014 Stroke kills almost

More information

Redgrave JN, Coutts SB, Schulz UG et al. Systematic review of associations between the presence of acute ischemic lesions on

Redgrave JN, Coutts SB, Schulz UG et al. Systematic review of associations between the presence of acute ischemic lesions on 6. Imaging in TIA 6.1 What type of brain imaging should be used in suspected TIA? 6.2 Which patients with suspected TIA should be referred for urgent brain imaging? Evidence Tables IMAG1: After TIA/minor

More information

Natural history of carotid artery occlusion contralateral to carotid endarterectomy

Natural history of carotid artery occlusion contralateral to carotid endarterectomy From the Southern Association for Vascular Surgery Natural history of carotid artery occlusion contralateral to carotid endarterectomy Ali F. AbuRahma, MD, Patrick A. Stone, MD, Shadi Abu-Halimah, MD,

More information

Endarterectomy for Mild Cervical Carotid Artery Stenosis in Patients With Ischemic Stroke Events Refractory to Medical Treatment

Endarterectomy for Mild Cervical Carotid Artery Stenosis in Patients With Ischemic Stroke Events Refractory to Medical Treatment Neurol Med Chir (Tokyo) 48, 211 215, 2008 Endarterectomy for Mild Cervical Carotid Artery Stenosis in Patients With Ischemic Stroke Events Refractory to Medical Treatment Two Case Reports Masakazu KOBAYASHI,

More information

Carotid Artery Stenting Today: A Few Updating Remarks

Carotid Artery Stenting Today: A Few Updating Remarks Carotid Artery Stenting Today: A Few Updating Remarks Camilo R. Gomez, MD, MBA Director, Alabama Neurological Institute Birmingham, Alabama Disclaimer & Warning Company Pharmaceutical BMS-Sanofi-Aventis

More information

Internal Carotid Artery Occlusion: Clinical and Therapeutic Implications

Internal Carotid Artery Occlusion: Clinical and Therapeutic Implications 94 Internal Carotid Artery Occlusion: Clinical and Therapeutic Implications VIVIAN U. FRITZ, M.D., CHRIS L. VOLL, M.D., AND LEWIS J. LEVIEN, M.D., PH.D. Downloaded from http://ahajournals.org by on November

More information

Carotid Artery Stenosis

Carotid Artery Stenosis Evidence-Based Approach to Carotid Artery Stenosis Seong-Wook Park, MD Division of Cardiology, Asan Medical Center University of Ulsan College of Medicine, Seoul, Korea Carotid Artery Stenosis Carotid

More information

Carotid Endarterectomy vs. Carotid artery Stenting (Surgeon Perspective)

Carotid Endarterectomy vs. Carotid artery Stenting (Surgeon Perspective) Carotid Endarterectomy vs. Carotid artery Stenting (Surgeon Perspective) T-Woei Tan, MD, FACS, RPVI Assistant Professor of Surgery Vascular and Endovascular Surgery Louisiana State University Health -

More information

HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM

HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM REVIEW DATE REVIEWER'S ID HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM : DISCHARGE DATE: RECORDS FROM: Hospitalization ER Please check all that may apply: Myocardial Infarction Pages 2, 3,

More information

Aortic arch pathology. Cerebral ischemia following carotid artery stenosis.

Aortic arch pathology. Cerebral ischemia following carotid artery stenosis. Important: -Subclavian Steal Syndrome -Cerebral ischemia Aortic arch pathology. Cerebral ischemia following carotid artery stenosis. Mina Aubeed & Alba Hernández Pinilla Aortic arch pathology Common arch

More information

Peter A. Soukas, M.D., FACC, FSVM, FSCAI, RPVI

Peter A. Soukas, M.D., FACC, FSVM, FSCAI, RPVI Peter A. Soukas, M.D., FACC, FSVM, FSCAI, RPVI Director, Peripheral Vascular Interventional Laboratory Director, Vascular & Endovascular Medicine Fellowship Program Assistant Professor of Medicine The

More information

PFO Management update

PFO Management update PFO Management update May 12, 2017 Peter Casterella, MD Swedish Heart and Vascular 1 PFO Update 2017: Objectives Review recently released late outcomes of RESPECT trial and subsequent FDA approval of PFO

More information

The contribution of the external carotid artery to cerebral perfusion in carotid disease

The contribution of the external carotid artery to cerebral perfusion in carotid disease The contribution of the external carotid artery to cerebral perfusion in carotid disease Shirley J. Fearn, PhD, FRCS, Andrew J. Picton, BSc, Andrew J. Mortimer, MD, FRCA, Andrew D. Parry, MBChB, FRCS,

More information

Screening and Management of Blunt Cereberovascular Injuries (BCVI)

Screening and Management of Blunt Cereberovascular Injuries (BCVI) Grady Memorial Hospital Trauma Service Guidelines Screening and Management of Blunt Cereberovascular Injuries (BCVI) BACKGROUND Blunt injury to the carotid or vertebral vessels (blunt cerebrovascular injury

More information

Contemporary Management of Carotid Disease What We Know So Far

Contemporary Management of Carotid Disease What We Know So Far Contemporary Management of Carotid Disease What We Know So Far Ammar Safar, MD, FSCAI, FACC, FACP, RPVI Interventional Cardiology & Endovascular Medicine Disclosers NONE Epidemiology 80 % of stroke are

More information

ESC Heart & Brain Workshop

ESC Heart & Brain Workshop ESC Heart & Brain Workshop The role of vascular surgeon in stroke prevention Barbara Rantner, MD, PhD, Department of Vascular Surgery, Medical University Innsbruck, Innsbruck, Austria Supported by Bayer,

More information

ORIGINAL INVESTIGATION. Relevance of Carotid Stenosis Progression as a Predictor of Ischemic Neurological Outcomes

ORIGINAL INVESTIGATION. Relevance of Carotid Stenosis Progression as a Predictor of Ischemic Neurological Outcomes ORIGINAL INVESTIGATION Relevance of Carotid Stenosis Progression as a Predictor of Ischemic Neurological Outcomes Daniel J. Bertges, MD; Visala Muluk, MD; Jeffrey Whittle, MD, MPH; Mary Kelley, MS; David

More information

How to manage the left subclavian and left vertebral artery during TEVAR

How to manage the left subclavian and left vertebral artery during TEVAR How to manage the left subclavian and left vertebral artery during TEVAR Jürg Schmidli Chief of Vascular Surgery Inselspital Hamburg 2017 Dept Cardiovascular Surgery, Bern, Switzerland Disclosure No Disclosures

More information

DESCRIPTION: Percent of asymptomatic patients undergoing CEA who are discharged to home no later than post-operative day #2

DESCRIPTION: Percent of asymptomatic patients undergoing CEA who are discharged to home no later than post-operative day #2 Measure #260: Rate of Carotid Endarterectomy (CEA) for Asymptomatic Patients, without Major Complications (Discharged to Home by Post-Operative Day #2) National Quality Strategy Domain: Patient Safety

More information

Management Strategy for Simultaneous Carotid Endarterectomy and Coronary Revascularization

Management Strategy for Simultaneous Carotid Endarterectomy and Coronary Revascularization Management Strategy for Simultaneous Carotid Endarterectomy and Coronary Revascularization Gregory D. Trachiotis, MD, and Albert J. Pfister, MD Washington Heart, Section for Thoracic and Cardiovascular

More information

DR.RUPNATHJI( DR.RUPAK NATH )

DR.RUPNATHJI( DR.RUPAK NATH ) 4. Screening for Asymptomatic Carotid Artery Stenosis Burden of Suffering RECOMMENDATION There is insufficient evidence to recommend for or against screening asymptomatic persons for carotid artery stenosis

More information

Carotid Artery Stenting

Carotid Artery Stenting Carotid Artery Stenting JESSICA MITCHELL, ACNP CENTRAL ILLINOIS RADIOLOGICAL ASSOCIATES External Carotid Artery (ECA) can easily be identified from Internal Carotid Artery (ICA) by noticing the branches.

More information

PAPER F National Collaborating Centre for Chronic Conditions at the Royal College of Physicians

PAPER F National Collaborating Centre for Chronic Conditions at the Royal College of Physicians 6.3 Early carotid imaging in acute stroke or TIA Evidence Tables IMAG4: Which patients with suspected stroke/tia should be referred for urgent carotid imaging? Reference Ahmed AS, Foley E, Brannigan AE

More information

Does female gender or hormone replacement therapy affect early or late outcome after carotid endarterectomy?

Does female gender or hormone replacement therapy affect early or late outcome after carotid endarterectomy? Does female gender or hormone replacement therapy affect early or late outcome after carotid endarterectomy? John S. Lane, MD, a Shant Shekherdimian, BS, b and Wesley S. Moore, MD, b Francisco, Calif Los

More information

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY Measure #260: Rate of Carotid Endarterectomy (CEA) for Asymptomatic Patients, without Major Complications (Discharged to Home by Post-Operative Day #2) National Quality Strategy Domain: Patient Safety

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Endovascular Therapies for Extracranial Vertebral Artery Disease File Name: Origination: Last CAP Review: Next CAP Review: Last Review: endovascular_therapies_for_extracranial_vertebral_artery_disease

More information

The Struggle to Manage Stroke, Aneurysm and PAD

The Struggle to Manage Stroke, Aneurysm and PAD The Struggle to Manage Stroke, Aneurysm and PAD In this article, Dr. Salvian examines the management of peripheral arterial disease, aortic aneurysmal disease and cerebrovascular disease from symptomatology

More information

Stroke is the third-leading cause of death and a major

Stroke is the third-leading cause of death and a major Long-Term Mortality and Recurrent Stroke Risk Among Chinese Stroke Patients With Predominant Intracranial Atherosclerosis Ka Sing Wong, MD; Huan Li, MD Background and Purpose The goal of this study was

More information

Surgical Treatment of Carotid Disease

Surgical Treatment of Carotid Disease Department of Cardiothoracic & Vascular Surgery McGovern Medical School / The University of Texas Health Science Center at Houston Surgical Treatment of Carotid Disease The Old, the New, and the Future

More information

Slide 1. Slide 2 Conflict of Interest Disclosure. Slide 3 Stroke Facts. The Treatment of Intracranial Stenosis. Disclosure

Slide 1. Slide 2 Conflict of Interest Disclosure. Slide 3 Stroke Facts. The Treatment of Intracranial Stenosis. Disclosure Slide 1 The Treatment of Intracranial Stenosis Helmi Lutsep, MD Vice Chair and Dixon Term Professor, Department of Neurology, Oregon Health & Science University Chief of Neurology, VA Portland Health Care

More information

Risk of Early Carotid Endarterectomy for Symptomatic Carotid Stenosis

Risk of Early Carotid Endarterectomy for Symptomatic Carotid Stenosis Risk of Early Carotid Endarterectomy for Carotid Stenosis Waleed Brinjikji, BS; Alejandro A. Rabinstein, MD; Fredric B. Meyer, MD; David G. Piepgras, MD; Giuseppe Lanzino, MD Background and Purpose The

More information

DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service

DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service M AY. 6. 2011 10:37 A M F D A - C D R H - O D E - P M O N O. 4147 P. 1 DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control

More information

Carotid Artery Stenting

Carotid Artery Stenting Carotid Artery Stenting Woong Chol Kang M.D. Gil Medical Center, Gachon University of Medicine and Science, Incheon, Korea Carotid Stenosis and Stroke ~25% of stroke is due to carotid disease, the reminder

More information

Polytetrafluoroethylene interposition grafts for carotid reconstruction

Polytetrafluoroethylene interposition grafts for carotid reconstruction Polytetrafluoroethylene interposition grafts for carotid reconstruction Michael J. Sise, MD, Michael E. Ivy, MD, Rose Malanche, CVT, and Kim R. Ranbarger, MD, San Diego, Calif. Polytetrafluoroethylene

More information

Recanalization of Chronic Carotid Artery Occlusion Objective Improvement Of Cerebral Perfusion

Recanalization of Chronic Carotid Artery Occlusion Objective Improvement Of Cerebral Perfusion Recanalization of Chronic Carotid Artery Occlusion Objective Improvement Of Cerebral Perfusion Paul Hsien-Li Kao, MD Assistant Professor National Taiwan University Medical School and Hospital ICA stenting

More information

The outcome of external carotid endarterectomy during routine carotid endarterectomy

The outcome of external carotid endarterectomy during routine carotid endarterectomy The outcome of external carotid endarterectomy during routine carotid endarterectomy Joseph P. Archie, Jr, PhD, MD, Raleigh, NC Purpose: This study is an analysis of the outcome of a common method of management

More information

Canadian Best Practice Recommendations for Stroke Care. (Updated 2008) Section # 3 Section # 3 Hyperacute Stroke Management

Canadian Best Practice Recommendations for Stroke Care. (Updated 2008) Section # 3 Section # 3 Hyperacute Stroke Management Canadian Best Practice Recommendations for Stroke Care (Updated 2008) Section # 3 Section # 3 Hyperacute Stroke Management Reorganization of Recommendations 2008 2006 RECOMMENDATIONS: 2008 RECOMMENDATIONS:

More information

Stroke 101. Maine Cardiovascular Health Summit. Eileen Hawkins, RN, MSN, CNRN Pen Bay Stroke Program Coordinator November 7, 2013

Stroke 101. Maine Cardiovascular Health Summit. Eileen Hawkins, RN, MSN, CNRN Pen Bay Stroke Program Coordinator November 7, 2013 Stroke 101 Maine Cardiovascular Health Summit Eileen Hawkins, RN, MSN, CNRN Pen Bay Stroke Program Coordinator November 7, 2013 Stroke Statistics Definition of stroke Risk factors Warning signs Treatment

More information

Stroke prevention in asymptomatic carotid stenosis. ΛΙΛΛΗΣ ΛΕΩΝΙΔΑΣ Καρδιολόγος Επιστημονικός Συνεργάτης Α Καρδιολογικής Κλινικής ΑΠΘ ΠΓΝΘ ΑΧΕΠΑ

Stroke prevention in asymptomatic carotid stenosis. ΛΙΛΛΗΣ ΛΕΩΝΙΔΑΣ Καρδιολόγος Επιστημονικός Συνεργάτης Α Καρδιολογικής Κλινικής ΑΠΘ ΠΓΝΘ ΑΧΕΠΑ Stroke prevention in asymptomatic carotid stenosis ΛΙΛΛΗΣ ΛΕΩΝΙΔΑΣ Καρδιολόγος Επιστημονικός Συνεργάτης Α Καρδιολογικής Κλινικής ΑΠΘ ΠΓΝΘ ΑΧΕΠΑ Σεμινάρια Ομάδων Εργασίας Ελληνικής Καρδιολογικής Εταιρείας

More information

Carotid Artery Stenting (CAS) Pathophysiology. Technical Considerations. Plaque characteristics: relevant concepts. CAS and CEA

Carotid Artery Stenting (CAS) Pathophysiology. Technical Considerations. Plaque characteristics: relevant concepts. CAS and CEA Carotid Artery Stenting (CAS) Carotid Artery Stenting for Stroke Risk Reduction Matthew A. Corriere MD, MS, RPVI Assistant Professor of Surgery Department of Vascular and Endovascular Surgery Rationale:

More information

Neurosurgical decision making in structural lesions causing stroke. Dr Rakesh Ranjan MS, MCh, Dip NB (Neurosurgery)

Neurosurgical decision making in structural lesions causing stroke. Dr Rakesh Ranjan MS, MCh, Dip NB (Neurosurgery) Neurosurgical decision making in structural lesions causing stroke Dr Rakesh Ranjan MS, MCh, Dip NB (Neurosurgery) Subarachnoid Hemorrhage Every year, an estimated 30,000 people in the United States experience

More information

Alma Mater Studiorum Università di Bologna

Alma Mater Studiorum Università di Bologna Alma Mater Studiorum Università di Bologna S.Orsola-Malpighi, Bologna, Italia Chirurgia Vascolare The volume of cerebral ischaemic lesion predicts the outcome after symptomatic carotid revascularisation

More information

Current Medical Therapy for

Current Medical Therapy for STROKE Current Medical Therapy for Stroke Prevention and Treatment Endovascular Today engages lipid expert Richard Milani, MD, and stroke expert Roekchai Tulyapronchote, MD, in a rapid-fire Q&A session.

More information

Open heart surgery or carotid endarterectomy. Which procedure should be done first?

Open heart surgery or carotid endarterectomy. Which procedure should be done first? Open heart surgery or carotid endarterectomy. Which procedure should be done first? Pedro Pinto Sousa 1, Gabriela Teixeira 2, João Gonçalves 2 ; Luís Vouga 1, Rui Almeida 2 ; Pedro Sá Pinto 2 1 Centro

More information

Amaurosis fugax: some aspects of management

Amaurosis fugax: some aspects of management Journal of Neurology, Neurosurgery, and Psvchiatry 1982;45:1-6 Amaurosis fugax: some aspects of management PJ PARKIN, BE KENDALL, J MARSHALL, WI McDONALD From the National Hospital for Nervous Diseases,

More information

Stroke/TIA. Tom Bedwell

Stroke/TIA. Tom Bedwell Stroke/TIA Tom Bedwell tab1g11@soton.ac.uk The Plan Definitions Anatomy Recap Aetiology Pathology Syndromes Brocas / Wernickes Investigations Management Prevention & Prognosis TIAs Key Definitions Transient

More information

Internal carotid artery near-total occlusions: Is it justified to operate on them?

Internal carotid artery near-total occlusions: Is it justified to operate on them? Internal carotid artery near-total occlusions: Is it justified to operate on them? Christos D. Liapis Professor (Em) of Vascular Surgery Athens University Medical School Director Vascular & Endovascular

More information

Endovascular and Hybrid Treatment of TASC C & D Aortoiliac Occlusive Disease

Endovascular and Hybrid Treatment of TASC C & D Aortoiliac Occlusive Disease Endovascular and Hybrid Treatment of TASC C & D Aortoiliac Occlusive Disease Arash Bornak, MD FACS Vascular & Endovascular Surgery University of Miami Miller School of Medicine No disclosure BACKGROUND

More information

Assessment of the procedural etiology of stroke resulting from carotid artery stenting

Assessment of the procedural etiology of stroke resulting from carotid artery stenting Assessment of the procedural etiology of stroke resulting from carotid artery stenting 1. Study Purpose and Rationale: A. Background Stroke is the 3 rd leading cause of death in the United States and carries

More information

WHI Form Report of Cardiovascular Outcome Ver (For items 1-11, each question specifies mark one or mark all that apply.

WHI Form Report of Cardiovascular Outcome Ver (For items 1-11, each question specifies mark one or mark all that apply. WHI Form - Report of Cardiovascular Outcome Ver. 6. COMMENTS To be completed by Physician Adjudicator Date Completed: - - (M/D/Y) Adjudicator Code: OMB# 095-044 Exp: 4/06 -Affix label here- Clinical Center/ID:

More information

ORIGINAL CONTRIBUTION. Long-term Risk of Stroke and Other Vascular Events in Patients With Asymptomatic Carotid Artery Stenosis

ORIGINAL CONTRIBUTION. Long-term Risk of Stroke and Other Vascular Events in Patients With Asymptomatic Carotid Artery Stenosis ORIGINAL CONTRIBUTION Long-term Risk of Stroke and Other Vascular Events in Patients With Asymptomatic Carotid Artery Stenosis Zurab G. Nadareishvili, MD, PhD; Peter M. Rothwell, MD, PhD; Vadim Beletsky,

More information

CORONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW

CORONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW CONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW 2015 PQRS OPTIONS F MEASURES GROUPS: 2015 PQRS MEASURES IN CONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP: #43 Coronary Artery Bypass Graft (CABG):

More information

Anticoagulants and Head Injuries. Asaad Shujaa,MD,FRCPC,FAAEM Assistant Professor,weill Corneal Medicne Senior Consultant,HMC Qatar

Anticoagulants and Head Injuries. Asaad Shujaa,MD,FRCPC,FAAEM Assistant Professor,weill Corneal Medicne Senior Consultant,HMC Qatar Anticoagulants and Head Injuries Asaad Shujaa,MD,FRCPC,FAAEM Assistant Professor,weill Corneal Medicne Senior Consultant,HMC Qatar Common Anticoagulants and Indications Coumadin (warfarin) indicated for

More information

Surgery for patients with diffuse atherosclerotic disease

Surgery for patients with diffuse atherosclerotic disease Surgery for patients with diffuse atherosclerotic disease Special hospital for surgery Skopje Macedonia September, 2012 Mitrev Z, Anguseva T, E.Stoicovski, Hristov N, E.Idoski Oktomvri, 2008 Atherosclerosis

More information

ESC Congress 2011 SIMULTANEOUS HYBRID REVASCULARIZATION OF CAROTID AND CORONARY DISEASE INITIAL RESULTS OF A NEW THERAPEUTIC APPROACH

ESC Congress 2011 SIMULTANEOUS HYBRID REVASCULARIZATION OF CAROTID AND CORONARY DISEASE INITIAL RESULTS OF A NEW THERAPEUTIC APPROACH ESC Congress 2011 SIMULTANEOUS HYBRID REVASCULARIZATION OF CAROTID AND CORONARY DISEASE IN PATIENTS WITH ACUTE CORONARY SYNDROME: INITIAL RESULTS OF A NEW THERAPEUTIC APPROACH AUTHORS: Marta Ponte 1, RICARDO

More information

Cerebrovascular Disease

Cerebrovascular Disease Cerebrovascular Disease I. INTRODUCTION Cerebrovascular disease (CVD) includes all disorders in which an area of the brain is transiently or permanently affected by ischemia or bleeding and one or more

More information

Apixaban for stroke prevention in atrial fibrillation. August 2010

Apixaban for stroke prevention in atrial fibrillation. August 2010 Apixaban for stroke prevention in atrial fibrillation August 2010 This technology summary is based on information available at the time of research and a limited literature search. It is not intended to

More information

Index. interventional.theclinics.com. Note: Page numbers of article titles are in boldface type.

Index. interventional.theclinics.com. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A ACAS (Asymptomatic Carotid Atherosclerosis Study), 65 66 ACST (Asymptomatic Carotid Surgery Trial), 6 7, 65, 75 Age factors, in carotid

More information

Non-Selective Carotid Artery Ultrasound Screening in Patients Undergoing Coronary Artery Bypass Grafting: Is It Necessary?

Non-Selective Carotid Artery Ultrasound Screening in Patients Undergoing Coronary Artery Bypass Grafting: Is It Necessary? Non-Selective Carotid Artery Ultrasound Screening in Patients Undergoing Coronary Artery Bypass Grafting: Is It Necessary? Khalil Masabni, Joseph F. Sabik III, Sajjad Raza, Theresa Carnes, Hemantha Koduri,

More information